Jackson Acquisition Company II
JACS.U · NYSE
About JACS.U
- Employees
- 0
- Headquarters
- Alpharetta, Georgia
- Listed
- Dec 10, 2024
- Sector
- N/A
- Industry
- N/A
- Website
- jacksonacquisitions.com
JACS.U key statistics
- Market cap
- 321.35M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 5
- Volume
- 103
- Open price
- $11.57
- High today
- $11.50
- Low today
- $11.50
- 52 Week high
- $12.75
- 52 Week low
- $10.60
Jackson Acquisition Company II (JACS.U) at a glance
As of Oct 28, 2026, Jackson Acquisition Company II (JACS.U) shares are priced at $11.50, giving the company a market cap of 321.35M and a price-to-earnings ratio of 0.00.
Volume so far is 103 shares, above the average of 5 shares a day.
Over the past year Jackson Acquisition Company II has ranged from $10.60 to $12.75, and now sits 42% of the way up that range.
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- DVLTDatavault AI$0.0879+31.19%
- RCTRedCloud Holdings$0.0617−5.95%
- TIPSTianrong Internet Products & Services$0.0014+27.27%
- GTVHGolden Triangle Ventures$0.0002+0.00%
- AITXArtificial Intelligence Technology Solutions$0.0005−43.75%
- CDTCDT Equity$0.083+3.75%
- EARIEntertainment Arts Research$0.0002+0.00%
- NBNDNetBrands$0.0006−14.29%
- NVDGraniteShares ETF Trust$4.01+2.04%
- STLAStellantis N.V$4.68+13.04%
- NTRRNeutra$0.0002+0.00%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.97−0.05%
- LYCALycia Therapeutics$25.05−4.06%
- DAVIDAVION HEALTHCARE$3.29+9.67%
- TCXBTCGX Acquisition Corp. II$10.27−0.10%
- CTYCITY THERAPEUTICS$21.65+3.79%
- IAMIambic Therapeutics$14.78+5.57%
- AMROAmaero$5.86−2.98%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.23−0.49%
- TRXBTRex Bio$14.43+4.64%
- RTSNRetension Pharmaceuticals$13.09−3.18%
- PAXGUPine Tree Acquisition$10.02+0.20%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.